Former Ripple executive Greg Kidd will acquire a controlling stake in Know Labs and launch a bitcoin financial strategy for the company.

According to news from Hash World, it has been reported that Know Labs, a publicly traded company focused on non-invasive health monitoring technology, has reached a controlling acquisition agreement with fintech investor Greg Kidd's company Goldeneye 1995 LLC. Kidd, who previously served as Ripple's Chief Risk Officer, will become the company's CEO and Chairman of the Board after the deal is completed. Under the agreement, the acquirer will complete the transaction at a price of $0.335 per share, using a combination of 1,000 bitcoins (based on current market price) and cash, with the cash portion used for debt repayment and to supplement operating funds. The bitcoins will be included on the company's balance sheet, accounting for 82% of the current market value, implying a valuation of 1.22 times. Greg Kidd plans to introduce a bitcoin revenue strategy to the public market. The company's founder, Ron Erickson, will transition to president of a new department and continue to lead technology development. The transaction has been unanimously approved by the board and is expected to be completed in the third quarter of 2025.